Centice competitors

Mr. Matthew T. Plavan is a Chief Executive Officer at THERMOGENESIS HOLDINGS, INC. and is based in United States.

Dr. Singh was elected President and Chief Executive Officer of PerkinElmer effective December 30, 2019, and appointed to our board of directors in August 2019. Previously Dr. Singh was the President and Chief Operating Officer of the Company since January 2019. Dr. Singh joined PerkinElmer as the President of our Diagnostics business in May 2014. He was elected Senior Vice President in September 2016 and Executive Vice President in March 2018. Prior to joining PerkinElmer, Dr. Singh was General Manager of GE Healthcare’s Women’s Health business from 2012 to 2014, with responsibility for its mammography and bone densitometry businesses. Before that, Dr. Singh held senior executive level roles in strategy, business development and mergers & acquisitions at both GE Healthcare and Philips Healthcare. Earlier in his career, he held leadership roles of increasing responsibility at DuPont Pharmaceuticals and subsequently Bristol-Myers Squibb Medical Imaging, which included managing the Asia Pacific and Middle East region. Dr. Singh holds a doctoral degree in chemistry from the University of Missouri-Columbia and a Master of Business Administration from Northeastern University. His research work has resulted in several issued patents and publications in peer reviewed journals. Dr. Singh has more than twenty-five years of leadership experience with global innovators in healthcare technology. He has spent the most recent six years developing unique insights into both our business and our opportunities for continued growth. Dr. Singh brings to our board a detailed understanding of the core technologies that we utilize and the operational strategies available to us as we continue to focus on innovating for a healthier world.

Thomas Mika previously served as the Chairman of the Board of Rennova Health, the successor company to CollabRx and its predecessor, Tegal Corporation, a semiconductor capital equipment company. On the Board of Directors of Tegal since its spin-out from Motorola in 1989, Mika assumed the roles of Chief Financial Officer in 2002, CEO in 2005 and Chairman & CEO in 2006, positions which he held until 2015. In 2015, Tegal merged with Rennova Health with Mika retaining the position of Chairman until joining POET in November 2016. Previously, Mika co-founded IMTEC, a boutique investment and consulting firm, serving clients in the U.S., Europe and Japan over a period of 20 years, taking on the role of CEO in several ventures. Earlier in his career, Mika was a managing consultant with Cresap, McCormick & Paget and a policy analyst for the National Science Foundation. He holds a Bachelor of Science in Microbiology from the University of Illinois at Urbana-Champaign and a Master of Business Administration from the Harvard Graduate School of Business.

Healthcare business executive with broad experience in product development, global marketing, commercialization and sales of medical devices. Strong background in market analysis, reimbursement strategy, regulatory and clinical affairs, new product development, sales force optimization and domestic and international product commercialization. Specialty experience working with medical societies, patient advocacy groups, governmental agencies, public and private insurance companies, investor relations, capital funding, business development and strategy development including strategic planning and acquisitions.

Ron Richard is a CEO at SeQual Technologies, Inc. and is based in San Diego, California. He works or has worked at O'Sullivan's Rainbow and works or has worked as Gerente General at Total Sleep Diagnostics, Sr. VP Strategic Marketing at ResMed Inc, and CEO & President at BLD Consulting. Ron studied at Baker University and Wichita South High School.

Gaurav Agarwal replaces Dave Eckley as the CEO of Vyaire Medical in Jan 2020. Prior to joining Vyaire Medical, Agarwal was president and chief operating officer of Acelity’s KCI. He has also served as president of orthopedic reconstruction at Smith & Nephew and VP and general manager of GE Healthcare.